Net Income Summary of Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited's latest annual net income in 2023 was 4.4 Billion ZAR , down -15.76% from previous year.
Aspen Pharmacare Holdings Limited's latest quarterly net income in 2023 Q2 was 2.31 Billion ZAR , up 100.0% from previous quarter.
Aspen Pharmacare Holdings Limited reported an annual net income of 5.22 Billion ZAR in 2022, down -19.42% from previous year.
Aspen Pharmacare Holdings Limited reported an annual net income of 6.48 Billion ZAR in 2021, up 35.0% from previous year.
Aspen Pharmacare Holdings Limited reported a quarterly net income of 2.09 Billion ZAR for 2023 Q4, down 0.0% from previous quarter.
Aspen Pharmacare Holdings Limited reported a quarterly net income of 1.15 Billion ZAR for 2023 Q1, down -54.7% from previous quarter.

Annual Net Income Chart of Aspen Pharmacare Holdings Limited (2023 - 2002)

Historical Annual Net Income of Aspen Pharmacare Holdings Limited (2023 - 2002)

Year	Net Income	Net Income Growth
2023	4.4 Billion ZAR	-15.76%
2022	5.22 Billion ZAR	-19.42%
2021	6.48 Billion ZAR	35.0%
2020	4.8 Billion ZAR	3.04%
2019	4.66 Billion ZAR	-27.84%
2018	6.46 Billion ZAR	7.54%
2017	6.01 Billion ZAR	17.84%
2016	5.1 Billion ZAR	18.6%
2015	4.3 Billion ZAR	-17.33%
2014	5.2 Billion ZAR	3.87%
2013	5 Billion ZAR	42.26%
2012	3.52 Billion ZAR	24.92%
2011	2.81 Billion ZAR	8.85%
2010	2.58 Billion ZAR	30.85%
2009	1.97 Billion ZAR	46.17%
2008	1.35 Billion ZAR	56.58%
2007	864.47 Million ZAR	20.46%
2006	717.66 Million ZAR	12.47%
2005	638.09 Million ZAR	29.17%
2004	493.99 Million ZAR	38.93%
2003	355.58 Million ZAR	30.05%
2002	273.41 Million ZAR	0.0%

Year	Net Income	Net Income Growth
2023 Q2	2.31 Billion ZAR	100.0%
2023 Q4	2.09 Billion ZAR	0.0%
2023 Q1	1.15 Billion ZAR	-54.7%
2022 Q4	2.55 Billion ZAR	100.0%
2022 Q1	1.33 Billion ZAR	-57.26%
2022 Q2	2.67 Billion ZAR	100.0%
2022 Q3	1.27 Billion ZAR	-52.24%
2022 FY	5.22 Billion ZAR	-19.42%
2021 Q1	1.68 Billion ZAR	-22.01%
2021 FY	6.48 Billion ZAR	35.0%
2021 Q2	3.36 Billion ZAR	100.0%
2021 Q3	1.56 Billion ZAR	-53.45%
2021 Q4	3.12 Billion ZAR	100.0%
2020 FY	4.8 Billion ZAR	3.04%
2020 Q3	1.26 Billion ZAR	-44.1%
2020 Q2	2.25 Billion ZAR	98.07%
2020 Q1	1.13 Billion ZAR	-47.99%
2020 Q4	2.15 Billion ZAR	70.88%
2019 Q3	1.08 Billion ZAR	-59.2%
2019 FY	4.66 Billion ZAR	-27.84%
2019 Q4	2.18 Billion ZAR	101.01%
2019 Q1	937.5 Million ZAR	214.33%
2019 Q2	2.66 Billion ZAR	184.69%
2018 Q2	1.34 Billion ZAR	0.0%
2018 FY	6.46 Billion ZAR	7.54%
2018 Q4	-820 Million ZAR	-87.43%
2018 Q3	-437.5 Million ZAR	-132.6%
2018 Q1	1.34 Billion ZAR	21.67%
2017 Q3	1.1 Billion ZAR	-35.4%
2017 Q1	1.7 Billion ZAR	46.69%
2017 FY	6.01 Billion ZAR	17.84%
2017 Q4	1.1 Billion ZAR	0.0%
2017 Q2	1.7 Billion ZAR	0.0%
2016 Q2	1.4 Billion ZAR	0.0%
2016 FY	5.1 Billion ZAR	18.6%
2016 Q4	1.16 Billion ZAR	0.0%
2016 Q3	1.16 Billion ZAR	-16.86%
2016 Q1	1.4 Billion ZAR	211.11%
2015 Q3	450 Million ZAR	-73.53%
2015 Q4	450 Million ZAR	0.0%
2015 FY	4.3 Billion ZAR	-17.33%
2015 Q1	1.7 Billion ZAR	24.1%
2015 Q2	1.7 Billion ZAR	0.0%
2014 Q1	1.23 Billion ZAR	-20.04%
2014 FY	5.2 Billion ZAR	3.87%
2014 Q4	1.36 Billion ZAR	0.0%
2014 Q3	1.36 Billion ZAR	11.36%
2014 Q2	1.23 Billion ZAR	0.0%
2013 FY	5 Billion ZAR	42.26%
2013 Q4	1.53 Billion ZAR	0.0%
2013 Q3	1.53 Billion ZAR	59.38%
2013 Q2	965.3 Million ZAR	0.0%
2013 Q1	965.3 Million ZAR	5.06%
2012 Q1	841.2 Million ZAR	26.13%
2012 Q3	918.85 Million ZAR	9.23%
2012 FY	3.52 Billion ZAR	24.92%
2012 Q4	918.85 Million ZAR	0.0%
2012 Q2	841.2 Million ZAR	0.0%
2011 Q3	666.92 Million ZAR	23.8%
2011 Q1	538.7 Million ZAR	0.0%
2011 Q4	666.92 Million ZAR	0.0%
2011 Q2	538.7 Million ZAR	0.0%
2011 FY	2.81 Billion ZAR	8.85%
2010 Q4	538.7 Million ZAR	0.0%
2010 Q2	443.82 Million ZAR	0.0%
2010 FY	2.58 Billion ZAR	30.85%
2010 Q3	538.7 Million ZAR	21.38%
2010 Q1	443.82 Million ZAR	0.0%
2009 Q3	443.82 Million ZAR	32.22%
2009 FY	1.97 Billion ZAR	46.17%
2009 Q1	335.67 Million ZAR	0.0%
2009 Q4	443.82 Million ZAR	0.0%
2009 Q2	335.67 Million ZAR	0.0%
2008 FY	1.35 Billion ZAR	56.58%
2008 Q4	335.67 Million ZAR	0.0%
2008 Q3	335.67 Million ZAR	55.32%
2008 Q2	216.11 Million ZAR	0.0%
2008 Q1	216.11 Million ZAR	0.0%
2007 Q1	179.41 Million ZAR	0.0%
2007 Q2	179.41 Million ZAR	0.0%
2007 Q3	216.11 Million ZAR	20.46%
2007 FY	864.47 Million ZAR	20.46%
2007 Q4	216.11 Million ZAR	0.0%
2006 Q3	179.41 Million ZAR	12.47%
2006 Q2	159.52 Million ZAR	0.0%
2006 Q1	159.52 Million ZAR	0.0%
2006 Q4	179.41 Million ZAR	0.0%
2006 FY	717.66 Million ZAR	12.47%
2005 Q1	123.49 Million ZAR	0.0%
2005 FY	638.09 Million ZAR	29.17%
2005 Q3	159.52 Million ZAR	29.17%
2005 Q4	159.52 Million ZAR	0.0%
2005 Q2	123.49 Million ZAR	0.0%
2004 Q1	88.89 Million ZAR	0.0%
2004 FY	493.99 Million ZAR	38.93%
2004 Q3	123.49 Million ZAR	38.93%
2004 Q4	123.49 Million ZAR	0.0%
2004 Q2	88.89 Million ZAR	0.0%
2003 Q2	68.35 Million ZAR	0.0%
2003 Q4	88.89 Million ZAR	0.0%
2003 Q3	88.89 Million ZAR	30.05%
2003 FY	355.58 Million ZAR	30.05%
2003 Q1	68.35 Million ZAR	0.0%
2002 FY	273.41 Million ZAR	0.0%
2002 Q4	68.35 Million ZAR	0.0%
2002 Q3	68.35 Million ZAR	0.0%

Peer Net Income Comparison of Aspen Pharmacare Holdings Limited

Name	Net Income	Net Income Difference

Global Stocks Search

Aspen Pharmacare Holdings Limited (APN.JO)

Net Income Summary of Aspen Pharmacare Holdings Limited

Annual Net Income Chart of Aspen Pharmacare Holdings Limited (2023 - 2002)

Historical Annual Net Income of Aspen Pharmacare Holdings Limited (2023 - 2002)

Peer Net Income Comparison of Aspen Pharmacare Holdings Limited